Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity

Published:2022-12 Issue: Volume:206 Page:115316
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Abdel-Aziz Amal Kamal,Dokla Eman M.E.,Abouzid Khaled A.M.,Minucci Saverio

Funder

Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Monzino

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference53 articles.

1. WHO, Cancer: Key facts, (2022). https://www.who.int/news-room/fact-sheets/detail/cancer (accessed March 26, 2022).

2. Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors;Milik;Eur. J. Med. Chem.,2018

3. Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents;Aziz;Sci. Rep.,2016

4. Discovery of a Novel Inhibitor of Histone Lysine-Speci fi c Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent;Vianello;J. Med. Chem.,2016

5. Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno[2,3-d]pyrimidine-based EGFR inhibitors;Milik;J. Mol. Struct.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics;Journal of Biochemical and Molecular Toxicology;2024-05-21

2. Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells;European Journal of Medicinal Chemistry;2024-03

3. Anti-Proliferative, Anti-EGFR and In Silico Studies of a Series of New Imidazole Tethered 1,2,4-Oxadiazoles;Polycyclic Aromatic Compounds;2023-09-19

4. Advances in acute myeloid leukemia differentiation therapy: A critical review;Biochemical Pharmacology;2023-09

5. Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development;Pharmaceuticals;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3